COVID-19 Rapid Antigen Test Market was valued at USD 6.03 Bn. in 2024, and total global COVID-19 Rapid Antigen Test Market revenue is expected to grow at a CAGR of 6.7% from 2025 to 2032, reaching nearly USD 10.13 Bn. Growing demand for fast and affordable testing.COVID-19 Rapid Antigen Test Market Overview:
One of the most important applications of these tests is rapid diagnostic screenings for COVID-19. They have brought various benefits to global governments and are commonly referred to as lateral flow tests. They are simple to use and require little training. They provide considerable cost savings, costing a fraction of traditional kinds of PCR testing and providing customers with results in 5–30 minutes. Rapid antigen tests have proven to be most effective when used in conjunction with mass testing or population-wide screening procedures. SARS-CoV-2 testing allows people to find out if they are contaminated. It prevents transmission by enabling individuals to protect themselves, their families, and communities.To know about the Research Methodology :- Request Free Sample Report In this report, the COVID-19 Rapid Antigen Test market's growth reasons, as well as the market's many segments (Product, Specimen Type, Technology, End User, and Region), are discussed. Data has been given by market players, regions, and specific requirements. This market report includes a comprehensive overview of all the significant improvements that are presently prevailing in all market segments. Key data analysis is presented in the form of statistics, infographics, and presentations. The study discusses the market's Drivers, Restraints, Opportunities, and Challenges. The report helps to assess the market growth drivers and determines how to use these drivers as a tool. The report also helps to rectify and resolve issues related to the global market situation.
COVID-19 Rapid Antigen Test Market Dynamics:
Rising global COVID-19 cases will increase the market share during the forecast timeline: One of the primary factors driving the growth of the market is the global increase in COVID-19 infections. The number of persons infected has grown dramatically. Also, even while vaccination rates are high, infected persons can still transfer the disease and fuel its spread. Such conditions boost demand for COVID-19 Rapid Antigen Test Market growth. There is a considerable demand for low-cost rapid-testing kits for large-scale testing to help control COVID-19 outbreaks, particularly in countries with weak healthcare systems such as India. Currently, India and the United States are the leading contributors to total COVID-19 cases worldwide. The increase in COVID-19 cases can also be attributed to the virus's development into newer forms. These considerations contribute to the demand for rapid mass testing. The growing number of firms entering this market coupled with increasing product approvals by the regulatory bodies across the globe. The FDA has approved 28 antigen diagnostic tests for COVID-19 diagnosis as of June 16, 2022. As a result, regulatory organizations play an important role in boosting the market growth. For example, Vatic Health, a U.K.-based company, received the CE mark in April 2022 for their COVID-19 viral on-the-spot' saliva antigen test. Many businesses have moved their attention from traditional PCR-based testing to antigen-based testing, believing it will be a valuable source of revenue in the coming years. Governments and manufacturers collaborate: Manufacturers of COVID-19 rapid test kits are increasingly getting into collaborations with governments for benefit. Governments are increasingly developing partnerships with local and international producers to address supply chain difficulties and the worldwide lack of fast test kits. For example, in May 2022, the Indian government announced a collaboration with Zydus Cadila, a Gujarat-based pharmaceutical company, to mass manufacture Elisa kits created by the Indian Council of Medical Research. Collaborations between governments and industry help in boosting production scale. Product Recalls: Product recalls owing to quality control issues are expected to hamper the growth of the COVID-19 Rapid Antigen Test Market during the forecast period. The rapid medical device approval due to the outbreak is expected to lead to a higher number of product recalls due to safety, effectiveness, and quality issues.COVID-19 Rapid Antigen Test Market Segment Analysis:
By Specimen Type, The Nasopharyngeal Swab segment dominated the COVID-19 Rapid Antigen Test Market in 2024. This method has been considered the gold standard for respiratory virus detection due to its high sensitivity and accuracy in collecting viral samples from the upper respiratory tract. During the height of the pandemic, global health authorities such as WHO and CDC widely recommended nasopharyngeal swabs for clinical and mass testing. Moreover, most professional-grade antigen testing kits were designed and validated using nasopharyngeal samples, which further boosted its adoption in hospitals and diagnostic labs. Although alternatives like nasal swabs and saliva gained traction for ease of use, especially in home settings, they still lag behind in diagnostic sensitivity. As a result, healthcare institutions continued to rely on nasopharyngeal swabs for critical patient testing, especially in symptomatic and high-risk cases, securing its dominance in the market. By End Users, in 2024, Hospitals were the dominant end-user segment in the COVID-19 Rapid Antigen Test Market. This was due to mandatory testing protocols for patient admissions, surgeries, and emergency care. Hospitals handled high volumes of symptomatic and high-risk patients, requiring fast and reliable testing. Their ability to bulk procure kits and deliver immediate care made them the most trusted testing centers. Additionally, government support and hospital infrastructure enabled large-scale, accurate testing.COVID-19 Rapid Antigen Test Market Regional Insights:
In North America, COVID-19 Rapid Antigen Test Market captured an 18% share in 2022. The regional growth is due to the presence of well-equipped, sophisticated healthcare facilities in the U.S. and Canada. Also, the increasing healthcare expenditure owing to growing awareness will augment the market share. Moreover, the increasing prevalence of Coronavirus infections along with healthcare expenditure is expected to fuel the market outlook in the coming years. Asia Pacific dominated the COVID-19 rapid antigen test market, accounting for 37.0 percent of total revenue in 2022. The presence of main players, the active development of SARS-CoV-2 antigen tests, and the introduction of various new products by budding start-ups have all contributed to the region's dominance. The objective of the report is to present a comprehensive analysis of the market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the market dynamics, and structure by analyzing the market segments and projecting the market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the market make the report investor’s guide.COVID-19 Rapid Antigen Test Market Scope: Inquire before buying
COVID-19 Rapid Antigen Test Market Report Coverage Details Base Year: 2024 Forecast Period: 2025-2032 Historical Data: 2019 to 2024 Market Size in 2024: USD 6.03 Bn. Forecast Period 2025 to 2032 CAGR: 6.7% Market Size in 2032: USD 10.13 Bn. Segments Covered: by Type Rapid Antigen Test Cassettes Immunoassay Test Strips Lateral Flow Assay Kits by Specimen Type Nasopharyngeal Swab Oropharyngeal Swab Nasal Swab by Technology Chromatographic Immunoassay Fluorescent Immunoassay Others by End-User Hospitals Diagnostic Laboratories Clinics Homecare Others COVID-19 Rapid Antigen Test Market, by Region
North America (United States, Canada, Mexico) Europe (Germany, United Kingdom, France, Italy, Spain, Netherlands, Sweden, Switzerland, Belgium, Russia, Poland, Finland, Norway, Austria, Ireland, Greece) South America (Brazil, Argentina, Chile, Colombia, Peru, Paraguay, Bolivia, Venezuela) Asia Pacific (China, India, Japan, Australia, South Korea, New Zealand, Singapore, Indonesia, Malaysia, Thailand, Vietnam, Philippines, Bangladesh) Middle East and Africa (Saudi Arabia, Qatar, Kuwait, Oman, South Africa, Nigeria, Israel, Jordan)COVID-19 Rapid Antigen Test Market Key Players are:
1. Abbott 2. Cipla 3. AMEDA Labordiagnostik GmbH 4. Becton Dickinson 5. Beijing Lepu Medical Technology 6. BIOSYNEX SWISS SA 7. CerTest Biotect S.L. 8. Hangzhou Clongene Biotech 9. Healgen Scientific Limited 10.LumiraDX UK Ltd. 11.nal von minden GmbH 12.Quidel Corporation 13.SD BIOSENSOR, Inc. 14.Roche 15.Siemens Healthineers 16.Xiamen Boson Biotech Co. 17.Zhejiang Orient Gene Biotech Co., Ltd Frequently Asked Questions 1. Which is the potential market for the COVID-19 Rapid Antigen Test in terms of the region? Ans. In the North America region, the presence of main players, the active development of SARS-CoV-2 antigen tests, and the introduction of various new products by budding start-ups have the potential market for the COVID-19 Rapid Antigen Test. 2. What is expected to drive the growth of the COVID-19 Rapid Antigen Test market in the forecast period? Ans. The Rising global COVID-19 cases will increase the market share during the forecast timeline. 3. What is the projected market size & growth rate of the COVID-19 Rapid Antigen Test Market? Ans. COVID-19 Rapid Antigen Test Market was valued at USD 6.03 billion in 2024, and total global market revenue is expected to grow at a CAGR of 6.7% from 2025 to 2032, reaching nearly USD 10.13 billion 4. What segments are covered in the COVID-19 Rapid Antigen Test Market report? Ans. The segments covered are Type, Specimen Type, Technology, End User, and Region.
1. COVID-19 Rapid Antigen Test Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global COVID-19 Rapid Antigen Test Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Key Players Benchmarking 2.3.1. Company Name 2.3.2. Business Segment 2.3.3. End-user Segment 2.3.4. Revenue (2024) 2.3.5. Company Locations 2.4. Leading COVID-19 Rapid Antigen Test Market Companies, by market capitalization 2.5. Market Structure 2.5.1. Market Leaders 2.5.2. Market Followers 2.5.3. Emerging Players 2.6. Mergers and Acquisitions Details 3. COVID-19 Rapid Antigen Test Market: Dynamics 3.1. COVID-19 Rapid Antigen Test Market Trends by Region 3.1.1. North America COVID-19 Rapid Antigen Test Market Trends 3.1.2. Europe COVID-19 Rapid Antigen Test Market Trends 3.1.3. Asia Pacific COVID-19 Rapid Antigen Test Market Trends 3.1.4. Middle East and Africa COVID-19 Rapid Antigen Test Market Trends 3.1.5. South America COVID-19 Rapid Antigen Test Market Trends 3.2. COVID-19 Rapid Antigen Test Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America COVID-19 Rapid Antigen Test Market Drivers 3.2.1.2. North America COVID-19 Rapid Antigen Test Market Restraints 3.2.1.3. North America COVID-19 Rapid Antigen Test Market Opportunities 3.2.1.4. North America COVID-19 Rapid Antigen Test Market Challenges 3.2.2. Europe 3.2.2.1. Europe COVID-19 Rapid Antigen Test Market Drivers 3.2.2.2. Europe COVID-19 Rapid Antigen Test Market Restraints 3.2.2.3. Europe COVID-19 Rapid Antigen Test Market Opportunities 3.2.2.4. Europe COVID-19 Rapid Antigen Test Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific COVID-19 Rapid Antigen Test Market Drivers 3.2.3.2. Asia Pacific COVID-19 Rapid Antigen Test Market Restraints 3.2.3.3. Asia Pacific COVID-19 Rapid Antigen Test Market Opportunities 3.2.3.4. Asia Pacific COVID-19 Rapid Antigen Test Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa COVID-19 Rapid Antigen Test Market Drivers 3.2.4.2. Middle East and Africa COVID-19 Rapid Antigen Test Market Restraints 3.2.4.3. Middle East and Africa COVID-19 Rapid Antigen Test Market Opportunities 3.2.4.4. Middle East and Africa COVID-19 Rapid Antigen Test Market Challenges 3.2.5. South America 3.2.5.1. South America COVID-19 Rapid Antigen Test Market Drivers 3.2.5.2. South America COVID-19 Rapid Antigen Test Market Restraints 3.2.5.3. South America COVID-19 Rapid Antigen Test Market Opportunities 3.2.5.4. South America COVID-19 Rapid Antigen Test Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For COVID-19 Rapid Antigen Test Industry 3.8. Analysis of Government Schemes and Initiatives For COVID-19 Rapid Antigen Test Industry 3.9. COVID-19 Rapid Antigen Test Market Trade Analysis 3.10. The Global Pandemic Impact on COVID-19 Rapid Antigen Test Market 4. COVID-19 Rapid Antigen Test Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2024-2032 4.1. COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 4.1.1. Rapid Antigen Test Cassettes 4.1.2. Immunoassay Test Strips 4.1.3. Lateral Flow Assay Kits 4.2. COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 4.2.1. Nasopharyngeal Swab 4.2.2. Oropharyngeal Swab 4.2.3. Nasal Swab 4.3. COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 4.3.1. Chromatographic Immunoassay 4.3.2. Fluorescent Immunoassay 4.3.3. Others 4.4. COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 4.4.1. Hospitals 4.4.2. Diagnostic Laboratories 4.4.3. Clinics 4.4.4. Homecare 4.4.5. Others 4.5. COVID-19 Rapid Antigen Test Market Size and Forecast, by Region (2024-2032) 4.5.1. North America 4.5.2. Europe 4.5.3. Asia Pacific 4.5.4. Middle East and Africa 4.5.5. South America 5. North America COVID-19 Rapid Antigen Test Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 5.1. North America COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 5.1.1. Rapid Antigen Test Cassettes 5.1.2. Immunoassay Test Strips 5.1.3. Lateral Flow Assay Kits 5.2. North America COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 5.2.1. Nasopharyngeal Swab 5.2.2. Oropharyngeal Swab 5.2.3. Nasal Swab 5.3. North America COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 5.3.1. Chromatographic Immunoassay 5.3.2. Fluorescent Immunoassay 5.3.3. Others 5.4. North America COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 5.4.1. Hospitals 5.4.2. Diagnostic Laboratories 5.4.3. Clinics 5.4.4. Homecare 5.4.5. Others 5.5. North America COVID-19 Rapid Antigen Test Market Size and Forecast, by Country (2024-2032) 5.5.1. United States 5.5.1.1. United States COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 5.5.1.1.1. Rapid Antigen Test Cassettes 5.5.1.1.2. Immunoassay Test Strips 5.5.1.1.3. Lateral Flow Assay Kits 5.5.1.2. United States COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 5.5.1.2.1. Nasopharyngeal Swab 5.5.1.2.2. Oropharyngeal Swab 5.5.1.2.3. Nasal Swab 5.5.1.3. United States COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 5.5.1.3.1. Chromatographic Immunoassay 5.5.1.3.2. Fluorescent Immunoassay 5.5.1.3.3. Others 5.5.1.4. United States COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 5.5.1.4.1. Hospitals 5.5.1.4.2. Diagnostic Laboratories 5.5.1.4.3. Clinics 5.5.1.4.4. Homecare 5.5.1.4.5. Others 5.5.2. Canada 5.5.2.1. Canada COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 5.5.2.1.1. Rapid Antigen Test Cassettes 5.5.2.1.2. Immunoassay Test Strips 5.5.2.1.3. Lateral Flow Assay Kits 5.5.2.2. Canada COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 5.5.2.2.1. Nasopharyngeal Swab 5.5.2.2.2. Oropharyngeal Swab 5.5.2.2.3. Nasal Swab 5.5.2.3. Canada COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 5.5.2.3.1. Chromatographic Immunoassay 5.5.2.3.2. Fluorescent Immunoassay 5.5.2.3.3. Others 5.5.2.4. Canada COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 5.5.2.4.1. Hospitals 5.5.2.4.2. Diagnostic Laboratories 5.5.2.4.3. Clinics 5.5.2.4.4. Homecare 5.5.2.4.5. Others 5.5.3. Mexico 5.5.3.1. Mexico COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 5.5.3.1.1. Rapid Antigen Test Cassettes 5.5.3.1.2. Immunoassay Test Strips 5.5.3.1.3. Lateral Flow Assay Kits 5.5.3.2. Mexico COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 5.5.3.2.1. Nasopharyngeal Swab 5.5.3.2.2. Oropharyngeal Swab 5.5.3.2.3. Nasal Swab 5.5.3.3. Mexico COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 5.5.3.3.1. Chromatographic Immunoassay 5.5.3.3.2. Fluorescent Immunoassay 5.5.3.3.3. Others 5.5.3.4. Mexico COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 5.5.3.4.1. Hospitals 5.5.3.4.2. Diagnostic Laboratories 5.5.3.4.3. Clinics 5.5.3.4.4. Homecare 5.5.3.4.5. Others 6. Europe COVID-19 Rapid Antigen Test Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 6.1. Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.2. Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.3. Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.4. Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5. Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Country (2024-2032) 6.5.1. United Kingdom 6.5.1.1. United Kingdom COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.1.2. United Kingdom COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.1.3. United Kingdom COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.1.4. United Kingdom COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.2. France 6.5.2.1. France COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.2.2. France COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.2.3. France COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.2.4. France COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.3. Germany 6.5.3.1. Germany COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.3.2. Germany COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.3.3. Germany COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.3.4. Germany COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.4. Italy 6.5.4.1. Italy COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.4.2. Italy COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.4.3. Italy COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.4.4. Italy COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.5. Spain 6.5.5.1. Spain COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.5.2. Spain COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.5.3. Spain COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.5.4. Spain COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.6. Sweden 6.5.6.1. Sweden COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.6.2. Sweden COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.6.3. Sweden COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.6.4. Sweden COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.7. Austria 6.5.7.1. Austria COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.7.2. Austria COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.7.3. Austria COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.7.4. Austria COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 6.5.8. Rest of Europe 6.5.8.1. Rest of Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 6.5.8.2. Rest of Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 6.5.8.3. Rest of Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 6.5.8.4. Rest of Europe COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7. Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 7.1. Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.2. Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.3. Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.4. Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5. Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Country (2024-2032) 7.5.1. China 7.5.1.1. China COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.1.2. China COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.1.3. China COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.1.4. China COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.2. S Korea 7.5.2.1. S Korea COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.2.2. S Korea COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.2.3. S Korea COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.2.4. S Korea COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.3. Japan 7.5.3.1. Japan COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.3.2. Japan COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.3.3. Japan COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.3.4. Japan COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.4. India 7.5.4.1. India COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.4.2. India COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.4.3. India COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.4.4. India COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.5. Australia 7.5.5.1. Australia COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.5.2. Australia COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.5.3. Australia COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.5.4. Australia COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.6. Indonesia 7.5.6.1. Indonesia COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.6.2. Indonesia COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.6.3. Indonesia COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.6.4. Indonesia COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.7. Malaysia 7.5.7.1. Malaysia COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.7.2. Malaysia COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.7.3. Malaysia COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.7.4. Malaysia COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.8. Vietnam 7.5.8.1. Vietnam COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.8.2. Vietnam COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.8.3. Vietnam COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.8.4. Vietnam COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.9. Taiwan 7.5.9.1. Taiwan COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.9.2. Taiwan COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.9.3. Taiwan COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.9.4. Taiwan COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 7.5.10. Rest of Asia Pacific 7.5.10.1. Rest of Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 7.5.10.2. Rest of Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 7.5.10.3. Rest of Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 7.5.10.4. Rest of Asia Pacific COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 8. Middle East and Africa COVID-19 Rapid Antigen Test Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 8.1. Middle East and Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 8.2. Middle East and Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 8.3. Middle East and Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 8.4. Middle East and Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 8.5. Middle East and Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Country (2024-2032) 8.5.1. South Africa 8.5.1.1. South Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 8.5.1.2. South Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 8.5.1.3. South Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 8.5.1.4. South Africa COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 8.5.2. GCC 8.5.2.1. GCC COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 8.5.2.2. GCC COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 8.5.2.3. GCC COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 8.5.2.4. GCC COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 8.5.3. Nigeria 8.5.3.1. Nigeria COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 8.5.3.2. Nigeria COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 8.5.3.3. Nigeria COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 8.5.3.4. Nigeria COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 8.5.4. Rest of ME&A 8.5.4.1. Rest of ME&A COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 8.5.4.2. Rest of ME&A COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 8.5.4.3. Rest of ME&A COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 8.5.4.4. Rest of ME&A COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 9. South America COVID-19 Rapid Antigen Test Market Size and Forecast by Segmentation (by Value in USD Million) 2024-2032 9.1. South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 9.2. South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 9.3. South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology(2024-2032) 9.4. South America COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 9.5. South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Country (2024-2032) 9.5.1. Brazil 9.5.1.1. Brazil COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 9.5.1.2. Brazil COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 9.5.1.3. Brazil COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 9.5.1.4. Brazil COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 9.5.2. Argentina 9.5.2.1. Argentina COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 9.5.2.2. Argentina COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 9.5.2.3. Argentina COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 9.5.2.4. Argentina COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 9.5.3. Rest Of South America 9.5.3.1. Rest Of South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Type (2024-2032) 9.5.3.2. Rest Of South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Specimen Type (2024-2032) 9.5.3.3. Rest Of South America COVID-19 Rapid Antigen Test Market Size and Forecast, by Technology (2024-2032) 9.5.3.4. Rest Of South America COVID-19 Rapid Antigen Test Market Size and Forecast, by End-User (2024-2032) 10. Company Profile: Key Players 10.1. Abbott 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Cipla 10.3. AMEDA Labordiagnostik GmbH 10.4. Becton Dickinson 10.5. Beijing Lepu Medical Technology 10.6. BIOSYNEX SWISS SA 10.7. CerTest Biotect S.L. 10.8. Hangzhou Clongene Biotech 10.9. Healgen Scientific Limited 10.10. LumiraDX UK Ltd. 10.11. nal von minden GmbH 10.12. Quidel Corporation 10.13. SD BIOSENSOR, Inc. 10.14. Roche 10.15. Siemens Healthineers 10.16. Xiamen Boson Biotech Co. 10.17. Zhejiang Orient Gene Biotech Co., Ltd 11. Key Findings 12. Industry Recommendations 13. COVID-19 Rapid Antigen Test Market: Research Methodology 14. Terms and Glossary
